Microbiology- Clinical Bacteriology (Gram -) Flashcards
Gram-negative lab algorithm
pag. 141
Neisseria Characteristics
Gram ⊝ diplococci. Metabolize glucose and produce IgA proteases. Contain lipooligosaccharides (LOS) with strong
endotoxin activity. N gonorrhoeae is often intracellular (within neutrophils).
Gonococci Characteristics, Clinical features, treatment
No polysaccharide capsule, Maltose not fermented, No vaccine due to antigenic variation of pilus proteins, Sexually or perinatally transmitted.
Causes gonorrhea, septic arthritis, neonatal conjunctivitis (2–5 days after birth), pelvic inflammatory disease (PID), and Fitz-Hugh– Curtis syndrome.
Treatment: ceftriaxone (+ azithromycin or doxycycline, for possible chlamydial coinfection).
Meningococci Characteristics, Clinical features, treatment
Polysaccharide capsule, Maltose fermentation, Vaccine (type B vaccine not widely available), Transmitted via respiratory and oral secretions.
Causes meningococcemia with petechial hemorrhages and gangrene of toes, meningitis, Waterhouse-Friderichsen syndrome (adrenal insufficiency, fever, DIC,
shock).
Treatment: ceftriaxone or penicillin G
Haemophilus influenzae Clinical features and treatment
HaEMOPhilus causes Epiglottitis (endoscopic appearance, can be “cherry red” in children; “thumb sign” on lateral neck x-ray), Meningitis, Otitis media, and Pneumonia.
Treatment: amoxicillin +/− clavulanate for mucosal infections; ceftriaxone for meningitis; rifampin prophylaxis for close contacts.
Haemophilus influenzae Characteristics, transmission, nontypeable strains, vaccine
Small gram ⊝ (coccobacillary) rod. Aerosol transmission. Nontypeable (unencapsulated) strains are the most common cause of mucosal infections (otitis media, conjunctivitis, bronchitis) as well as invasive infections since the vaccine for capsular type b was introduced.
Produces IgA protease.
Vaccine contains type b capsular polysaccharide (polyribosylribitol phosphate) conjugated to diphtheria toxoid or other protein. Given between 2 and 18 months of age.
Bordetella pertussis Clinical features
Catarrhal—low-grade fevers, Coryza.
Paroxysmal—paroxysms of intense cough followed by inspiratory “whooP” (“whooping cough”), posttussive vomiting.
Convalescent—gradual recovery of chronic cough.
Prevented by Tdap, DTaP vaccines. May be mistaken as viral infection due to lymphocytic infiltrate resulting from immune response.
Legionella pneumophila Characteristics, Transmission, Treatment
Gram stains poorly—use silver stain. Grow on charcoal yeast extract medium with iron and cysteine. Detected by
presence of antigen in urine. Labs may show hyponatremia.
Aerosol transmission from environmental water source habitat.
Treatment: macrolide or quinolone.
Legionnaires’ disease
Pontiac fever
severe pneumonia (often unilateral and lobar A ), fever, GI and CNS symptoms. Common in smokers and in chronic lung disease.
mild flu-like syndrome.
Treatments Pseudomonas aeruginosa
Include “CAMPFIRE” drugs:
Carbapenems
Aminoglycosides
Monobactams
Polymyxins (eg, polymyxin B, colistin)
Fluoroquinolones (eg, ciprofloxacin, levofloxacin)
ThIRd- and fourth-generation cephalosporins (eg, ceftazidime, cefepime).
Extended-spectrum penicillins (eg, piperacillin, ticarcillin)
PSEUDOMONAS is associated with:
Pneumonia, Sepsis, Ecthyma gangrenosum, UTIs, Diabetes, Osteomyelitis, Mucoid polysaccharide capsule, Otitis externa (swimmer’s ear), Nosocomial infections (eg,
catheters, equipment), Addicts (drug abusers), Skin infections (eg, hot tub folliculitis, wound infection in burn victims).
Pseudomonas aeruginosa Produces PEEP:
Phospholipase C (degrades cell membranes); Endotoxin (fever, shock); Exotoxin A (inactivates EF-2); Pigments: pyoverdine and pyocyanin
Ecthyma gangrenosum
Rapidly progressive, necrotic cutaneous lesion caused by
Pseudomonas bacteremia. Typically seen in immunocompromised patients.
Pseudomonas aeruginosa Characteristics
Aeruginosa—aerobic; motile, gram ⊝ rod. Nonlactose
fermenting. Oxidase ⊕. Frequently found in water. Has a grape-like odor.
Salmonella vs Shigella
pag. 144